1,272
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Complications after 100 sessions of cone-beam computed tomography-guided lung radiofrequency ablation: a single-center, retrospective experience

ORCID Icon, ORCID Icon, , , &
Pages 763-771 | Received 23 Jan 2020, Accepted 13 Jun 2020, Published online: 03 Jul 2020

References

  • de Baere T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240(2):587–596.
  • Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621–628.
  • de Baere T, Auperin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26(5):987–991.
  • Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Intervent Radiol. 2013;30(2):141–150.
  • Mouli SK, Kurilova I, Sofocleous CT, et al. The role of percutaneous image-guided thermal ablation for the treatment of pulmonary malignancies. AJR Am J Roentgenol. 2017;209(4):740–751.
  • Carlson SK, Felmlee JP, Bender CE, et al. CT fluoroscopy-guided biopsy of the lung or upper abdomen with a breath-hold monitoring and feedback system: a prospective randomized controlled clinical trial. Radiology. 2005;237(2):701–708.
  • Orth RC, Wallace MJ, Kuo MD. C-arm cone-beam CT: general principles and technical considerations for use in interventional radiology. J Vasc Interv Radiol. 2008;19(6):814–820.
  • Choo JY, Park CM, Lee NK, et al. Percutaneous transthoracic needle biopsy of small (≤1 cm) lung nodules under C-arm cone-beam CT virtual navigation guidance. Eur Radiol. 2013;23(3):712–719.
  • Lee SM, Park CM, Lee KH, et al. C-arm cone-beam CT-guided percutaneous transthoracic needle biopsy of lung nodules: clinical experience in 1108 patients. Radiology. 2014;271(1):291–300.
  • Rotolo N, Floridi C, Imperatori A, et al. Comparison of cone-beam CT-guided and CT fluoroscopy-guided transthoracic needle biopsy of lung nodules. Eur Radiol. 2016;26(2):381–389.
  • Cheng YC, Tsai SH, Cheng Y, et al. Percutaneous transthoracic lung biopsy: comparison between C-arm cone-beam CT and conventional CT guidance. Transl Oncol. 2015;8(4):258–264.
  • Cazzato RL, Battistuzzi JB, Catena V, et al. Cone-Beam Computed Tomography (CBCT) versus CT in lung ablation procedure: which is faster? Cardiovasc Intervent Radiol. 2015;38(5):1231–1236.
  • Amouyal G, Pernot S, Dean C, et al. Percutaneous radiofrequency ablation of lung metastases from colorectal carcinoma under C-arm cone beam CT guidance. Diagn Interv Imaging. 2017;98(11):793–799.
  • Xiang ZJ, Wang Y, Du EF, et al. The value of cone-beam CT-guided radiofrequency ablation in the treatment of pulmonary malignancies (≤3 cm). Biosci Rep. 2019;39(2):pii:BSR20181230.
  • Zhu JC, Yan TD, Glenn D, et al. Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg. 2009;87(4):1023–1028.
  • Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol. 2008;31(1):122–130.
  • Kashima M, Yamakado K, Takaki H, et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. AJR Am J Roentgenol. 2011;197(4):W576–580.
  • Welch BT, Brinjikji W, Schmit GD, et al. A national analysis of the complications, cost, and mortality of percutaneous lung ablation. J Vasc Interv Radiol. 2015;26(6):787–791.
  • Braak SJ, van Strijen MJ, van Leersum M, et al. Real-time 3D fluoroscopy guidance during needle interventions: technique, accuracy, and feasibility. AJR Am J Roentgenol. 2010;194(5):W445–451.
  • Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol. 2018;41(10):1530–1544.
  • Cho J, Yoon J, Kim Y, et al. Linguistic validation of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events in Korean. J Glob Oncol. 2019;5:1–10.
  • Yang Q, Qi H, Zhang R, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a review of 147 tumors. J Vasc Interv Radiol. 2017;28(4):481–489.
  • MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii18–31.
  • Li G, Xue M, Chen W, et al. Efficacy and safety of radiofrequency ablation for lung cancers: a systematic review and meta-analysis. Eur J Radiol. 2018;100:92–98.
  • Hiraki T, Gobara H, Fujiwara H, et al. Lung cancer ablation: complications. Semin Intervent Radiol. 2013;30(02):169–175.
  • Nour-Eldin NE, Naguib NN, Saeed AS, et al. Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms. AJR Am J Roentgenol. 2009;193(1):W43–48.
  • Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241(1):275–283.
  • Yamagami T, Kato T, Hirota T, et al. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol. 2006;17(10):1625–1629.
  • Kennedy SA, Milovanovic L, Dao D, et al. Risk factors for pneumothorax complicating radiofrequency ablation for lung malignancy: a systematic review and meta-analysis. J Vasc Interv Radiol. 2014;25(11):1671–1681.e1671.
  • Nour-Eldin NE, Naguib NN, Mack M, et al. Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern. Eur Radiol. 2011;21(1):197–204.
  • Vaughn C, Mychaskiw G, 2nd, Sewell P. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg. 2002;94(5):1149–1151.
  • Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243(1):268–275.
  • Sakurai J, Hiraki T, Mukai T, et al. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol. 2007;18(1 Pt 1):141–145.
  • Cannella M, Cornelis F, Descat E, et al. Bronchopleural fistula after radiofrequency ablation of lung tumours. Cardiovasc Intervent Radiol. 2011;34(Suppl 2):S171–S174.
  • Mackln CC. Transport of air along sheaths of pulmonic blood vessels from alveoli to mediastinum. Arch Intern Med. 1939;64:913–926.
  • Smith SL, Bowers D, Jennings P, et al. Pulmonary radiofrequency ablation in a district general hospital: is it a safe and effective treatment? Clin Radiol. 2016;71:939.e931.
  • Aufranc V, Farouil G, Abdel-Rehim M, et al. Percutaneous thermal ablation of primary and secondary lung tumors: comparison between microwave and radiofrequency ablation. Diagn Interv Imaging. 2019;100(12):781–791.
  • Jin KN, Park CM, Goo JM, et al. Initial experience of percutaneous transthoracic needle biopsy of lung nodules using C-arm cone-beam CT systems. Eur Radiol. 2010;20(9):2108–2115.
  • de Baere T, Tselikas L, Catena V, et al. Percutaneous thermal ablation of primary lung cancer. Diagn Interv Imaging. 2016;97(10):1019–1024.
  • Prud’homme C, Deschamps F, Moulin B, et al. Image-guided lung metastasis ablation: a literature review. Int J Hyperthermia. 2019;36(2):37–45.